Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology

Nuria Padulles Zamora

PRINCIPAL INVESTIGATORS
  • Pedro Alia Ramos
  • Beatriz Candas Estebanez
  • Elisabet Leiva Badosa
  • Helena Colom Codina
CLINICAL RESEARCHERS
  • Roser Juvany Roig
  • Ariadna Padulles Zamora
  • Maria Badia Tahull
  • Josep Maria Suñe Negre
  • Montserrat Miñarro Carmona
  • Josep Ramon Tico Grau
  • Ariadna Padro Miquel
  • Pilar Perez Lozano
  • Encarna Garcia Montoya
  • Núria Llecha Cano
RESEARCH EMERITUS
  • Josep Llop Talaveron
PREDOCTORAL RESEARCHERS (R1)
  • Ana Suárez-Lledó Grande
  • Eugènia Santacana Juncosa
  • Sara Cobo Sacristan
  • Marc Suñé Pou
  • Montserrat Colls Gonzalez
  • Erika Esteve Pitarch
SCIENTIFIC SUPPORT
  • Ana Ferrer Artola
MANAGEMENT SUPPORT
  • Ramon Jodar Masanes
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention

Scientific production

12

PAPERS

1 PUBLICATIONS IN FIRST DECILE

3 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Ruiz-Iruela C., Candás-Estébanez B., Pintó-Sala X., Baena-Díez N., Caixàs-Pedragós A., Güell-Miró R., Navarro-Badal R., Calmarza P., Puzo-Foncilla J.L., Alía-Ramos P., Padró-Miquel A.. Genetic contribution to lipid target achievement with statin therapy: a prospective study. PHARMACOGENOMICS JOURNAL. 10.1038/s41397-019-0136-7
  • Colls-Gonzalez M., Notario-Rosa J., Bas-Minguet J., Padullés-Zamora A., Morandeira-Rego F., Valentí-Medina F., Colom-Codina H., Padullés-Zamora N.. Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study. JOURNAL OF DERMATOLOGICAL TREATMENT. 10.1080/09546634.2019.1690623
  • Padullés Zamora A., Juvany Roig R., Leiva Badosa E., Sabater Riera J., Pérez Fernández X.L., Cárdenas Campos P., Rigo Bonin R., Alía Ramos P., Tubau Quintano F., Sospedra Martinez E., Colom Codina H.. Optimized meropenem dosage regimens using a pharmacokinetic/pharmacodynamic population approach in patients undergoing continuous venovenous haemodiafiltration with high-adsorbent membrane. THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 10.1093/jac/dkz299

Research highlights

PROJECTS

5 Ongoing projects
2 Started projects

3 Ongoing clinical trials

PUBLISHED WORKS

3 Theses

Selected projects

  • Ajut HUB Recerca Clínica (18/4/2018 – 30/6/2021) PI: LEIVA BADOSA, ELISABET. Funder: HOSPITAL UNIVERSITARI DE BELLVITGE.
  • Antibiotic plasma level concentrations during continuous renal replacement therapy with a high absorptive membrane (oXiris®) (1/1/2019 – 31/12/2021) PI: COLOM CODINA, HELENA. Funder: BAXTER, S.L..
  • CONVENIO ROCHE (1/4/2019 – 31/3/2020) PI: JODAR MASANES, RAMON. Funder: ROCHE FARMA S.A..
  • Investigació i desenvolupament galènic (formulació, tècnica d’elaboració, analítica, equivalència “in vitro” i estabilitat) d’un nou medicament genèric d’ús veterinari: comprimits de trilostano 20 mg i 80 mg (8/5/2018 – 31/12/2022) PI: JM Suñé Negre. Funder ref.: FBG nº 309835.
  • Ensayo clínico para evaluar el comportamiento farmacocinético de meropenem en membranas de adsorción incrementada (Oxiris®) en el paciente crítico séptico con disfunción renal aguda. (1/1/2012 – 31/12/2019) PI: JUVANY ROIG, ROSER.
  • Omega 3 fatty acids as a complementary therapy to jejunostomy feeding in esofaguectomized patients (1/1/2015 – ) PI: LEIVA BADOSA, ELISABET.